Society of Nuclear Medicine and Molecular Imaging (SNMMI)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), formerly the Society of Nuclear Medicine, is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging (PET and SPECT). The bulk of nuclear imaging exams relate to oncology, about a third to cardiac imaging and the rest for a variety of protocols, including imaging inflammation and beta-amyloid plaques that cause Alzheimer's disease. 

Prostate Blue Ribbon

Imaging advocacy group warns of supply shortage that’s having ‘profound negative impact’ on patient care

Radiologists took to Twitter to voice their frustrations over the worsening situation, while the manufacturer issued an update Thursday.   

March 9, 2023
FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

September 30, 2022
Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been detected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

August 26, 2022
An example of a positive amyloid plaque PET nuclear brain scan. these tests can help identify Alzheimer's patients earlier so they can be prescribed drugs to treat the condition.

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

April 18, 2022
brain money alzheimer dementia

Imaging industry advocate slams feds’ failure to address PET coverage gap in recent ruling

The Society for Nuclear Medicine & Molecular Imaging expressed "strong opposition" following CMS' decision, arguing there is no evidence to support limiting pay for such scans. 

April 11, 2022

FDA approves new therapy, complementary imaging agent for treating metastatic prostate cancer

Provider advocates praised the decision, calling it “one of the greatest success stories in nuclear medicine history.”

March 24, 2022
The U.S. Congress is working on healthcare legislation to fix medicare reimbursements and end annual cuts to physicians.

Several medical imaging societies ask to be involved in Congressional Medicare reform efforts

Numerous medical imaging societies, including the ACR, signed onto a letter dated Feb. 25 that was sent to members of Congress requesting collaboration on reforms to the Medicare physician payment system.

February 25, 2022
brain money alzheimer dementia

Imaging advocate concerned after CMS grants limited coverage of controversial Alzheimer’s drug, related PET scans

SNMMI believes the proposed payment pathway will prevent patients' access to diagnosis and treatment.

January 12, 2022

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology

Peninsula Imaging told Mary Raver in 2014 that a cancerous growth was benign. She now has 18 months to live.

Trimed Popup
Trimed Popup